Purchase Order 75N93018P00797
Award Date 6/7/18
Potential Completion Date 7/7/18
Potential Value $13K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Competed under SAP
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Burien, WA 98168, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
3
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The U.S. National Institute of Allergy and Infectious Diseases, a civilian agency within the Department of Health and Human Services, awarded a Firm Fixed Price Blanket Purchase Agreement (BPA) Call contract worth $14,934.75 to Stemcell Technologies Inc., a foreign-owned for-profit biotechnology company. The contract is for the supply of the EASYSEP NEGATIVE HUMAN CD4 KIT, Catalog #19052. This product supports biomedical and scientific research, particularly in areas like infectious diseases,...
- This is a firm fixed-price purchase order awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the National Institutes of Health (NIH) within the Department of Health and Human Services (HHS), to Stemcell Technologies Inc., a Canadian biotechnology company. The contract, valued at $5,636.00, is for the delivery of EasySep Negative Human CD4 Kits, which are specialized cell isolation products used to support biomedical research. Stemcell Technologies Inc....
- This federal contract award was made by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the Department of Health and Human Services (HHS), to Stemcell Technologies Inc., a Canadian biotechnology company. The $6,699 firm fixed-price contract is for the delivery of EasySep Negative Human CD4 Kits, which are specialized cell isolation products used to support biomedical research, particularly in areas like immunology and infectious disease investigations....
- The Department of Health and Human Services National Institutes of Health National Institute of Allergy and Infectious Diseases awarded a $100,836.00 firm-fixed-price purchase order contract to Stemcell Technologies Inc., a Canadian-owned for-profit company, to provide EASYSEP ENRICHMENT KITS. This contract has a performance period from July 5, 2017 to July 5, 2018 and was not set aside for a particular type of small business. Stemcell Technologies Inc. is an established federal contractor...
- This firm fixed-price purchase order was awarded by the National Institutes of Health (NIH) National Institute of Allergy and Infectious Diseases to Stemcell Technologies Inc., a Canadian-owned for-profit organization, on August 6, 2019. The $24,069.90 contract is for the delivery of EasySep Negative Human CD4 Kits and EasySep Negative Human CD8 Kits, which are specialized biological products used in life sciences research. This sole-source award was made under the authority of 41 U.S.C....
- This federal contract award to Stemcell Technologies Inc., a Canadian biotechnology company, was issued by the National Institute of Allergy and Infectious Diseases (NIAID), a sub-agency of the U.S. Department of Health and Human Services (HHS). The $24,536.00 firm fixed-price purchase order is for the provision of the AMBIS 1787964 QUOTE Q-921198 item, which is described as the "EASY STEP NEGATIVE HUMAN CD4 KIT". The award does not have a small business set-aside designation. Stemcell...
- The National Institute of Allergy and Infectious Diseases (NIAID), a sub-agency of the U.S. Department of Health and Human Services (HHS), awarded a $80,536.00 firm-fixed-price purchase order contract to Stemcell Technologies Inc. for EasySep Negative Human CD4 and CD8 Kits. This contract does not have a set-aside designation. Stemcell Technologies Inc. is a Canadian biotechnology company that specializes in cell culture media, cell separation systems, and other life sciences research...
- The Department of Health and Human Services' National Institutes of Health (NIH) National Institute of Allergy and Infectious Diseases awarded a $17,450.00 Firm Fixed Price purchase order contract to Stemcell Technologies Inc., a Canadian-owned for-profit organization, for the delivery of HUMAN CD8 KITS. The contract has a completion date of June 22, 2018 and does not have a set-aside designation. Stemcell Technologies Inc. is an active supplier of specialized biological materials, laboratory...
- The Department of Health and Human Services National Institutes of Health National Institute of Allergy and Infectious Diseases awarded a $15,645.00 Firm Fixed Price Purchase Order to Stemcell Technologies Inc., a foreign-owned for-profit organization, for the provision of HUMAN CD8 KITS. This award was not set aside for any specific business category. Stemcell Technologies Inc. is a subsidiary of the Canadian company Stemcell Technologies, which develops cell culture media, cell separation...
- This federal contract award, valued at $22,786.00, was issued by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the National Institutes of Health (NIH), to Stemcell Technologies Inc., a Canadian biotechnology company. The contract is for the delivery of the EasySep Negative Human CD4 Kit, a specialized cell isolation product used to support biomedical research initiatives, particularly in the areas of immunology, infectious disease, and stem cell studies. The...